• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Erratum to: Correlation between S-1 treatment outcome and expression of biomarkers for refractory thymic carcinoma.

作者信息

Okuma Yusuke, Hosomi Yukio, Miyamoto Shingo, Shibuya Masahiko, Okamura Tatsuru, Hishima Tsunekazu

机构信息

Department of Thoracic Oncology and Respiratory Medicine, Tokyo Metropolitan Cancer and Infectious diseases Center Komagome Hospital, 3-18-22 Honkomagome, Bunkyo, Tokyo, 113-8677, Japan.

Division of Oncology, Research Center for Medical Sciences, The Jikei University School of Medicine, Minato, Tokyo, Japan.

出版信息

BMC Cancer. 2016 Apr 15;16:272. doi: 10.1186/s12885-016-2309-y.

DOI:10.1186/s12885-016-2309-y
PMID:27084341
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4833961/
Abstract
摘要

相似文献

1
Erratum to: Correlation between S-1 treatment outcome and expression of biomarkers for refractory thymic carcinoma.《难治性胸腺癌S-1治疗结果与生物标志物表达之间的相关性》勘误
BMC Cancer. 2016 Apr 15;16:272. doi: 10.1186/s12885-016-2309-y.
2
Results of S-1-based chemotherapy for platinum (and antrathycline)-refractory advanced thymic carcinoma.基于S-1的化疗用于铂类（及蒽环类）难治性晚期胸腺癌的结果。
Anticancer Res. 2014 Oct;34(10):5743-7.
3
Immunohistochemical KIT (CD117) expression in thymic epithelial tumors.免疫组化检测KIT（CD117）在胸腺上皮肿瘤中的表达
Chest. 2005 Jul;128(1):140-4. doi: 10.1378/chest.128.1.140.
4
Expression of thymidylate synthase, orotate phosphoribosyltransferase and dihydropyrimidine dehydrogenase in thymic epithelial tumors.胸苷酸合成酶、乳清酸磷酸核糖转移酶和二氢嘧啶脱氢酶在胸腺瘤中的表达。
Lung Cancer. 2011 Dec;74(3):419-25. doi: 10.1016/j.lungcan.2011.04.001. Epub 2011 May 7.
5
Diagnostic utility of thymic epithelial markers CD205 (DEC205) and Foxn1 in thymic epithelial neoplasms.胸腺上皮标志物CD205（DEC205）和Foxn1在胸腺上皮肿瘤中的诊断效用
Am J Surg Pathol. 2007 Jul;31(7):1038-44. doi: 10.1097/PAS.0b013e31802b4917.
6
Medical treatment involving investigational drugs and genetic profile of thymic carcinoma.涉及研究性药物的医学治疗及胸腺癌的基因概况。
Lung Cancer. 2016 Mar;93:77-81. doi: 10.1016/j.lungcan.2016.01.004. Epub 2016 Jan 11.
7
Role of PAX-8, CD5, and CD117 in distinguishing thymic carcinoma from poorly differentiated lung carcinoma.PAX-8、CD5和CD117在鉴别胸腺癌与低分化肺癌中的作用。
Appl Immunohistochem Mol Morphol. 2014 May-Jun;22(5):372-6. doi: 10.1097/PAI.0b013e318297cdb5.
8
Response to cytotoxic chemotherapy in patients previously treated with palliative-intent chemotherapy for advanced thymic carcinoma.先前接受姑息性化疗的晚期胸腺癌患者对细胞毒性化疗的反应。
Clin Lung Cancer. 2015 May;16(3):221-7. doi: 10.1016/j.cllc.2014.10.006. Epub 2014 Oct 31.
9
Methylation and expression profiles of MGMT gene in thymic epithelial tumors.MGMT 基因在胸腺瘤中的甲基化和表达谱。
Lung Cancer. 2014 Feb;83(2):279-87. doi: 10.1016/j.lungcan.2013.12.004. Epub 2013 Dec 21.
10
Interleukin-6-producing undifferentiated thymic carcinoma with neuroendocrine features.具有神经内分泌特征的产生白细胞介素-6的未分化胸腺癌。
Lung Cancer. 2009 Mar;63(3):425-9. doi: 10.1016/j.lungcan.2008.07.018. Epub 2008 Sep 19.

本文引用的文献

1
Correlation between S-1 treatment outcome and expression of biomarkers for refractory thymic carcinoma.S-1治疗难治性胸腺癌的疗效与生物标志物表达之间的相关性
BMC Cancer. 2016 Feb 25;16:156. doi: 10.1186/s12885-016-2159-7.